Parental iron preparation enumerate, indication, adverse effect, oral iron preparation enumerate, indications , uses adverse effect, iron deficiency anemia- drug treatment enumerate, iron poisoning enumerate - antidotes, treatment 2nd yr mbbs detail answer pharmacology refer kd tripathi add diagrams and flowchart as well

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Generating Image
Generating Image
Generating Image
Generating Image
Here is your complete, detailed 2nd Year MBBS Pharmacology answer on Iron - covering all asked topics with diagrams and flowcharts, based on KD Tripathi principles supplemented from Katzung, Lippincott, and Rosen's Emergency Medicine.

IRON PHARMACOLOGY - Complete 2nd MBBS Answer


IRON ABSORPTION - Mechanism (Essential Background)

Iron Absorption Pathway
Iron exists in two forms:
  • Fe²+ (Ferrous) - absorbed form
  • Fe³+ (Ferric) - storage/dietary form (must be reduced first)
Absorption pathway (Duodenum and upper jejunum):
DIETARY IRON (Fe³⁺ / Haem iron)
         ↓
Gastric acid + Vitamin C → reduces Fe³⁺ to Fe²⁺
         ↓
Ferrireductase (Dcytb) on brush border
         ↓
DMT-1 transporter → enters enterocyte
         ↓
    ┌────────────────────────────────┐
    │         ENTEROCYTE             │
    │  • Stored as FERRITIN         │
    │  • (mucosal block mechanism)  │
    │  • OR exported via FERROPORTIN│
    └────────────────────────────────┘
         ↓ (ferroportin)
Plasma → binds TRANSFERRIN (Fe³⁺)
         ↓
  BONE MARROW → Hb synthesis
  LIVER/SPLEEN/BM → stored as FERRITIN/HEMOSIDERIN
Hepcidin (liver hormone) inhibits ferroportin → blocks iron release from enterocytes and macrophages. In iron deficiency, hepcidin falls → more iron absorbed.
Normal daily requirement:
  • Men: 1 mg/day
  • Premenopausal women: 2 mg/day
  • Pregnant women: 3-4 mg/day

SECTION 1: ORAL IRON PREPARATIONS

Enumerate - Oral Iron Preparations

PreparationTablet SizeElemental IronDose (Adult)
Ferrous Sulfate (most used)325 mg65 mg (20%)2-4 tabs/day
Ferrous Gluconate325 mg36 mg (11%)3-4 tabs/day
Ferrous Fumarate325 mg106 mg (33%)2-3 tabs/day
Ferrous Succinate-~35%2-3 tabs/day
Ferric Ammonium Citrate-~18%Syrup form
Carbonyl Iron-~100%Slower absorption, safer
Ferric Hydroxide Polymaltose (IPC)-~20%Less GI side effects
Key Point (KD Tripathi): Ferrous salts (Fe²⁺) are better absorbed than ferric salts (Fe³⁺). Ferrous sulfate is the cheapest and most widely used.
Elemental iron content (mnemonic - "Fumarate is the FAT one"):
  • Fumarate = 33% (highest)
  • Sulfate = 20%
  • Gluconate = 11% (lowest)

Indications for Oral Iron

  1. Iron deficiency anemia (IDA) - most common indication
  2. Prophylaxis during pregnancy (National Iron + Folic Acid supplementation program)
  3. Premature infants and rapid growth periods in children
  4. Menorrhagia / chronic blood loss - menstruating women
  5. Post-gastrectomy (if absorption is adequate)
  6. Nutritional deficiency states

Mechanism of Action

  • Oral iron provides elemental iron for incorporation into hemoglobin in erythroid precursors in bone marrow
  • ~50-100 mg of iron can be incorporated into Hb daily
  • ~25% of ferrous iron from oral preparation is absorbed
  • So 200-400 mg elemental iron/day needed for rapid correction

Uses / Dose

  • Therapeutic dose: 200 mg elemental iron/day in 3 divided doses (equivalent to ~300 mg ferrous sulfate TDS)
  • Prophylactic dose: 60 mg elemental iron + 500 mcg folic acid daily (in pregnancy)
  • Continue treatment 3-6 months after Hb normalizes (to replenish stores)
  • Expected Hb rise: ~1 g/dL/week after adequate treatment

Adverse Effects of Oral Iron

GI Side Effects (most common, dose-related):

Side EffectMechanism
Nausea, vomitingDirect gastric irritation
Epigastric discomfortLocal mucosal irritation
ConstipationMost common (Fe²⁺ precipitates sulfides → slows motility)
DiarrheaOsmotic effect in some patients
Abdominal cramps
Black tarry stoolsIron sulfide formation (no clinical significance per se, but may mask GI bleeding)

How to minimize GI side effects:

  • Take with food (reduces absorption ~30-50% but improves tolerance)
  • Start with lower dose and titrate up
  • Change to a different iron salt
  • Use liquid formulation (children)
  • Enteric-coated tablets (reduce GI side effects but also reduce absorption)

Other adverse effects:

  • Tooth staining - liquid preparations (use straw)
  • Metallic taste
  • Darkening of teeth (in liquid forms)

Interactions:

  • Tetracyclines, fluoroquinolones, antacids - chelate iron, reduce absorption
  • Vitamin C (ascorbic acid) - ENHANCES iron absorption (reduces Fe³⁺ to Fe²⁺)
  • Tea, coffee, phytates - reduce iron absorption
  • Give iron 1 hour before or 2 hours after these drugs/foods

SECTION 2: PARENTERAL IRON PREPARATIONS

Enumerate - Parenteral Iron Preparations

PreparationRouteKey Features
1. Iron Dextran (INFeD)IM / IVOldest; high risk of anaphylaxis; test dose mandatory
2. Sodium Ferric Gluconate (Ferrlecit)IV onlyLower anaphylaxis risk; used in dialysis patients
3. Iron Sucrose (Venofer)IV onlySafest; most widely used; preferred in CKD
4. Ferric Carboxymaltose (Ferinject)IV onlyHigh dose possible in single infusion; no test dose
5. Ferumoxytol (Feraheme)IV onlySuperparamagnetic; very rapid infusion; used in CKD
6. Low Molecular Weight Iron DextranIV onlyLess allergenic than high MW form
KD Tripathi Note: Iron dextran is a stable complex of ferric oxyhydroxide and dextran polymers containing 50 mg elemental iron/mL.

Indications for Parenteral Iron

  1. Intolerance to oral iron (persistent GI side effects)
  2. Malabsorption syndromes (celiac disease, Crohn's of proximal small bowel)
  3. Post-gastrectomy / short bowel syndrome - inadequate intestinal surface
  4. Inflammatory bowel disease (IBD) involving proximal small bowel
  5. Chronic kidney disease (CKD) on hemodialysis + EPO therapy - PREFERRED route
  6. Functional iron deficiency in cancer patients on erythropoiesis-stimulating agents
  7. Non-compliance with oral iron
  8. Rapid iron repletion required (pre-operative patients)
  9. Severe IDA where oral route is too slow

Adverse Effects of Parenteral Iron

Iron Dextran - Specific Risks:

Adverse EffectDetails
Anaphylaxis/Anaphylactoid reactionMost serious; 1-2% risk; test dose MANDATORY (25 mg IV over 5 min, wait 1 hr)
Delayed serum-sickness type reactionFever, arthralgia, myalgia, lymphadenopathy (Days 1-2 after injection)
HypotensionEspecially with rapid IV infusion
Pain at IM siteBrown staining of skin with IM injection (use Z-track technique)

All Parenteral Iron - General Side Effects:

Adverse EffectDetails
Pain/phlebitisAt injection site
Headache, dizziness
Nausea
Flushing, hypotensionWith rapid infusion
Iron overloadIf given excessively (hemosiderosis)
Chest pain, dyspneaRare with rapid infusion

Iron Sucrose / Ferric Carboxymaltose (Safer profile):

  • Much lower risk of anaphylaxis compared to iron dextran
  • No test dose required for iron sucrose and ferric carboxymaltose
  • Ferric carboxymaltose: most common side effect is transient hypophosphatemia

Calculation of parenteral iron dose (Iron Dextran):

Total iron (mg) = Weight (kg) × 2.3 × (Target Hb - Actual Hb) + 500
                                              (g/dL)
OR
= 0.3 × Body weight (lbs) × (100 - [Hb × 100/14.8])

SECTION 3: IRON DEFICIENCY ANEMIA - DRUG TREATMENT

Enumerate: Drug Treatment of IDA

IDA Treatment Flowchart
                    DIAGNOSIS OF IDA
          ┌──────────────────────────────┐
          │ • Low Hb (microcytic,        │
          │   hypochromic)               │
          │ • Low MCV (<80 fL)           │
          │ • Low serum ferritin (<20)   │
          │ • Low serum iron (<30 mcg/dL)│
          │ • High TIBC                  │
          │ • Transferrin sat <10%       │
          └──────────────┬───────────────┘
                         ↓
              TREAT UNDERLYING CAUSE
                         +
                IRON SUPPLEMENTATION
                         ↓
            ┌────────────────────────────┐
            │     FIRST LINE:            │
            │   ORAL IRON THERAPY        │
            │                            │
            │ • Ferrous Sulfate 200mg    │
            │   elemental iron/day       │
            │   (in 3 divided doses)     │
            │ • Continue 3-6 months      │
            │   after Hb normalizes      │
            └──────────┬─────────────────┘
                       │
          ┌────────────┴──────────────┐
          │ Indications for IV/IM     │
          │ (Parenteral Iron):        │
          │ • Intolerance to oral     │
          │ • Malabsorption           │
          │ • CKD + dialysis + EPO    │
          │ • IBD (proximal bowel)    │
          │ • Post-gastrectomy        │
          │ • Non-compliance          │
          └────────────┬──────────────┘
                       ↓
            PARENTERAL IRON THERAPY
            (Iron sucrose preferred)

Drug Treatment - Enumerated List:

A. Oral Iron (First Line):
  1. Ferrous Sulfate - 325 mg TDS (standard first choice)
  2. Ferrous Gluconate - 325 mg TDS/QID
  3. Ferrous Fumarate - 325 mg BD/TDS
  4. Carbonyl iron (slow release, better GI tolerance)
  5. Ferric polymaltose complex (IPC) - better GI tolerance, less interaction with food
B. Parenteral Iron (Second Line - specific indications):
  1. Iron Sucrose (Venofer) - 200 mg IV in 100 mL NS over 15 min
  2. Ferric Carboxymaltose (Ferinject) - up to 1000 mg single dose
  3. Sodium Ferric Gluconate - 125 mg IV per session
  4. Iron Dextran - IM or IV (test dose required)
  5. Ferumoxytol - 510 mg IV; two doses over 3-8 days
C. Adjuncts:
  • Folic acid (if co-deficiency, common in pregnancy)
  • Vitamin C (500 mg) with iron - enhances absorption
  • Erythropoietin in CKD patients (given WITH parenteral iron)
  • Blood transfusion - reserved for Hb <7 g/dL with severe symptoms

Monitoring Response to Iron Therapy:

ParameterExpected Change
ReticulocytosisPeaks at 5-10 days (earliest sign of response)
Hb rise~1 g/dL/week
Hb normalization4-8 weeks
Iron stores replenished3-6 months after Hb normal
Serum ferritinNormalizes last
Exam Point: If no response to oral iron after 4 weeks, check: compliance, ongoing blood loss, malabsorption, wrong diagnosis.

SECTION 4: IRON POISONING - ANTIDOTES AND TREATMENT

Iron Poisoning - Overview

  • Most common in children who accidentally ingest parents' iron tablets or prenatal vitamins
  • Toxic dose: >20 mg/kg elemental iron = toxic; >60 mg/kg = potentially lethal
  • Fatal dose in children: as low as 200-250 mg elemental iron/kg

Stages of Iron Toxicity (KD Tripathi / Rosen's Emergency Medicine)

Stages of Iron Poisoning
StageTimingFeaturesMechanism
Stage I - GI Phase0-6 hoursVomiting, diarrhea, hematemesis, abdominal pain, GI bleedingDirect corrosive effect of iron on GI mucosa
Stage II - Latent Phase6-24 hoursApparent clinical improvementRedistribution of iron from GI to systemic circulation
Stage III - Systemic Toxicity12-48 hoursMetabolic acidosis, shock, hypotension, lethargy, coma, coagulopathy, hepatotoxicityFree iron catalyzes free radical formation (Fenton reaction) → mitochondrial damage, impaired oxidative phosphorylation
Stage IV - Hepatic Necrosis2-5 daysJaundice, liver failure, coagulopathyIron deposits in hepatocytes
Stage V - Late Complications2-6 weeksGI strictures, pyloric stenosis, bowel obstructionFibrosis from GI mucosal injury
Mnemonic for stages: "GI Lies Sick Having Stenosis" (GI, Latent, Systemic, Hepatic, Strictures)

Mechanism of Iron Toxicity

Free Iron (Fe²⁺/Fe³⁺) in excess
         ↓
Fenton Reaction:
Fe²⁺ + H₂O₂ → Fe³⁺ + OH⁻ + OH• (hydroxyl radical)
         ↓
Lipid peroxidation of cell membranes
         ↓
Mitochondrial dysfunction
         ↓
↓ ATP production
         ↓
Cell death in: Liver, Heart, CNS, GI mucosa
         ↓
Metabolic acidosis (lactic acidosis) + Multi-organ failure

Iron Poisoning - Antidotes

PRIMARY ANTIDOTE: DEFEROXAMINE (Desferrioxamine)

Deferoxamine Mechanism
Mechanism:
Deferoxamine + Fe³⁺ → FERRIOXAMINE (water-soluble chelate)
                              ↓
                    Renally excreted
                    ("Vin rose" / pink-orange colored urine)
  • Deferoxamine chelates free iron (Fe³⁺) specifically
  • Does NOT chelate iron from hemoglobin, transferrin, or ferritin (selective - only free ionic iron)
  • Forms ferrioxamine - excreted in urine (pink/orange = sign of effective chelation)
Dose and Route:
RouteDoseIndication
IV (preferred)15 mg/kg/hr as continuous infusion (max 35 mg/kg/hr in severe cases)Severe poisoning
IM90 mg/kg (max 1 g per dose) every 8 hoursModerate poisoning
Indications for Deferoxamine:
  1. Serum iron >500 mcg/dL
  2. Serum iron >300 mcg/dL with symptoms
  3. Metabolic acidosis
  4. Lethargy, hypotension, signs of shock
  5. Severe GI symptoms (regardless of measured level)
Duration: Continue until urine color returns to normal (ferrioxamine no longer being excreted) AND patient clinically improves - usually 24 hours; NOT >24 hours unless severe toxicity.
Adverse Effects of Deferoxamine:
  • Hypotension (rapid infusion)
  • ARDS (with prolonged infusion >24 hours)
  • Yersinia sepsis (deferoxamine is a siderophore for Yersinia)
  • Tachycardia, urticaria, flushing
  • Cataracts with prolonged use (chronic use in thalassemia)

Full Treatment of Iron Poisoning - Enumerate

IRON POISONING MANAGEMENT
         │
         ├─── 1. STABILIZE (ABC)
         │         Airway, Breathing, Circulation
         │         IV access, O₂, fluids for shock
         │
         ├─── 2. DECONTAMINATION
         │         • Gastric lavage (if within 1-2 hr of ingestion)
         │         • Activated charcoal - NOT effective for iron
         │           (iron does not adsorb to AC)
         │         • Whole Bowel Irrigation (WBI) with
         │           polyethylene glycol (PEG) solution
         │           - if radiopaque tablets visible on X-ray
         │           - Rate: 250-500 mL/hr (child) or
         │             1.5-2 L/hr (adult) until effluent clear
         │
         ├─── 3. ANTIDOTE - DEFEROXAMINE
         │         • IV: 15 mg/kg/hr continuous infusion
         │         • Indication: serum Fe >500 mcg/dL
         │           OR severe symptoms
         │         • Monitor: vin rose urine
         │         • Duration: max 24 hours continuous
         │
         ├─── 4. SUPPORTIVE CARE
         │         • Correct metabolic acidosis (sodium bicarbonate)
         │         • Fluid resuscitation for hemorrhagic shock
         │         • Vasopressors if refractory hypotension
         │         • Correct coagulopathy
         │         • Monitor liver function tests
         │
         ├─── 5. DIALYSIS / EXCHANGE TRANSFUSION
         │         • Hemodialysis - NOT effective
         │           (iron has large Vd)
         │         • Exchange transfusion - only if not
         │           responding to chelation (rare)
         │
         └─── 6. MONITORING
                   • Serum iron (3-5 hr post ingestion,
                     repeat at 6-8 hr)
                   • LFTs, PT/INR, electrolytes, ABG
                   • Abdominal X-ray (radiopaque tablets)

Summary Table: Iron Poisoning Treatment

StepTreatmentNotes
DecontaminationWhole bowel irrigationActivated charcoal NOT used
Specific antidoteDeferoxamine (IV)15 mg/kg/hr; vin rose urine = working
Metabolic acidosisNaHCO₃
ShockIV fluids, vasopressors
Hepatic failureSupportiveLFT monitoring
Enhanced eliminationNOT dialysisLarge volume of distribution
Late stricturesSurgicalPyloric/bowel strictures (Stage V)

QUICK REVISION TABLES

Oral vs Parenteral Iron - Comparison

FeatureOral IronParenteral Iron
First choiceYesNo (reserved)
Absorption~25%100%
CostCheapExpensive
GI side effectsYes (common)No
Anaphylaxis riskNoYes (iron dextran)
ConvenienceDaily tabletsHospital/clinic visit
Test dose neededNoYes (iron dextran)
Preferred in CKD+EPONoYes
Onset of Hb rise2-4 weeksFaster
Iron overload riskLow (mucosal block)Higher

Mnemonic - Indications for Parenteral Iron: "MAGIC"

  • M - Malabsorption
  • A - Advanced CKD / hemodialysis
  • G - GI intolerance to oral iron
  • I - IBD (proximal bowel)
  • C - Compliance failure / post-gastrectomy

Mnemonic for Iron Deficiency Lab Findings: "Low SFTM, High T"

  • Low Serum iron
  • Low Ferritin
  • Low Transferrin saturation (<10%)
  • Low MCV, MCH, MCHC
  • High TIBC (Total Iron Binding Capacity)

Key Drug Interactions

Drug/FoodEffect on Iron
Vitamin C↑ absorption (reduces Fe³⁺ → Fe²⁺)
Tetracyclines↓ absorption (chelation)
Fluoroquinolones↓ absorption
Antacids (Mg, Al, Ca)↓ absorption
Proton pump inhibitors↓ absorption (need acid for Fe³⁺ → Fe²⁺)
Tea, coffee, phytates↓ absorption
Milk/dairy↓ absorption

SOURCES

  • Katzung's Basic & Clinical Pharmacology, 16e - Chapter 33 (Agents Used in Anemias)
  • Lippincott Illustrated Reviews: Pharmacology - Chapter 44 (Iron) & Chapter 46 (Toxicology)
  • Rosen's Emergency Medicine - Chapter 146 (Iron Toxicity)
  • KD Tripathi Essentials of Medical Pharmacology - Chapter on Haematinics

HIGH-YIELD EXAM POINTS (2nd MBBS)

  1. Iron sucrose is the safest parenteral iron (preferred in pregnancy and CKD)
  2. Activated charcoal does NOT adsorb iron - a common MCQ trap
  3. Vin rose (pink-orange) urine = sign that deferoxamine is working
  4. Deferoxamine chelates ONLY free iron, not iron in Hb/transferrin/ferritin
  5. Deferoxamine >24 hours continuous infusion → risk of ARDS and Yersinia sepsis
  6. Ferrous fumarate has highest elemental iron content (33%)
  7. Black stools with oral iron = normal, clinically insignificant (but may mask GI bleeding)
  8. Reticulocytosis peaks at 5-10 days = earliest sign of response to iron therapy
  9. Stage II (latent phase) of iron poisoning = dangerous - patient seems to recover but systemic toxicity is developing
  10. Iron dextran requires test dose - other parenteral irons (sucrose, carboxymaltose) do not
This is a shared conversation. Sign in to Orris to start your own chat.